P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-383, A BCMA × CD3 BISPECIFIC T-CELL–REDIRECTING ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

por Weisel, Katja, D’souza, Anita, Hurd, David, Voorhees, Peter, Teipel, Raphael, Chung, Alfred, Rodriguez, Cesar, Tuchman, Sacha, Korde, Neha, Safah, Hana, Bueno, Orlando, Feng, Zhongling, Rosenberg, Tanya, Kumar Pothacamury, Rajvineeth, Ross, Jeremy, Lee, Shane, Jin, Ziyi, Talati, Chetasi, Kumar, Shaji, Vij, Ravi
Publicado 2023